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Abstract Intra-arterial radiotherapy with yttrium-90
microspheres (radioembolization) is a therapeutic proce-
dure exclusively applied to the liver that allows the direct
delivery of high-dose radiation to liver tumors, by means of
endovascular catheters, selectively placed within the tumor
vasculature. The aim of the study was to describe the
distribution of spheres within the precapillaries, inflam-
matory response, and recannalization characteristics after
embolization with nonradioactive resin microspheres in the
kidney and liver. We performed a partial embolization of
the liver and kidney vessels in nine white pigs. The left
renal and left hepatic arteries were catheterized and filled
with nonradioactive resin microspheres. Embolization was
defined as the initiation of near-stasis of blood flow, rather
than total occlusion of the vessels. The hepatic circulation
was not isolated so that the effects of reflux of micro-
spheres into stomach could be observed. Animals were
sacrificed at 48 h, 4 weeks, and 8 weeks, and tissue sam-
ples from the kidney, liver, lung, and stomach evaluated.
Microscopic evaluation revealed clusters of 10–30 micro-
spheres (15–30 lm in diameter) in the small vessels of the
kidney (the arciform arteries, vasa recti, and glomerular
afferent vessels) and liver. Aggregates were associated
with focal ischemia and mild vascular wall damage.
Occlusion of the small vessels was associated with a mild
perivascular inflammatory reaction. After filling of the left
hepatic artery with microspheres, there was some evidence
of arteriovenous shunting into the lungs, and one case of
cholecystitis and one case of marked gastritis and ulcera-
tion at the site of arterial occlusion due to the presence of
clusters of microspheres. Beyond 48 h, microspheres were
progressively integrated into the vascular wall by phago-
cytosis and the lumen recannalized. Eight-week evaluation
found that the perivascular inflammatory reaction was
mild. Liver cell damage, bile duct injury, and portal space
fibrosis were not observed. In conclusion, resin micro-
spheres (15–30 lm diameter) trigger virtually no inflam-
matory response in target tissues (liver and kidney).
Clusters rather than individual microspheres were associ-
ated with a mild to moderate perivascular inflammatory
reaction. There was no evidence of either a prolonged
inflammatory reaction or fibrosis in the liver parenchyma
following recannalization.
Keywords Embolization  Experimental 
Radioembolization
Introduction
Intra-arterial radiotherapy with yttrium-90 (90Y) micro-
spheres (radioembolization) is a therapeutic procedure
exclusively applied to the liver that allows the direct
delivery of high-dose radiation to liver tumors by means of
endovascular catheters, selectively placed within the tumor
vasculature [1]. Like other regional treatments for liver
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tumors, this procedure utilizes the well-characterized dual
vasculature of the liver to selectively target tumors larger
than 5 mm that are almost exclusively supplied by blood
from the hepatic arterial branches. The small microspheres
(*30 lm in diameter), loaded with 90Y, preferentially
lodge within the tumor microvasculature, delivering high-
energy b-radiation over a limited range (mean penetration
of radiation into tissues, 2.4 mm), thereby confining the
tumoricidal dose ([70 Gy) to the immediate proximity of
the tumor and sparing the normal liver parenchyma [2].
By contrast, conventional embolization of liver tumors,
with either TAE (transarterial embolization) or TACE
(transarterial chemoembolization), is usually performed
with particles larger than 100 lm. The particles fill the
vessels that feed the tumor, provoking embolization and
subsequent tumoral ischemia with or without the delivery
of drugs to the tumor environment. Smaller particles for
TAE/TACE should be used with much care because of the
increased risk of adverse distal embolization due to arte-
riovenous shunting and particles passing through tumoral
and nontumoral capillary bed [3].
Two nonbiodegradable microspheres are now commer-
cially available for radioembolization: glass 20- to 30-lm-
diameter microspheres with an activity of 2500 Bq per
particle (size and activity as provided by manufacturer:
TheraSphere; MDS Nordion, Canada) and resin 20- to 60-
lm-diameter microspheres with an activity of 50 Bq per
particle (size and activity as provided by manufacturer:
SIR-Spheres; Sirtex Medical, Sydney, Australia). Both
devices have been extensively evaluated worldwide as
adjuncts to chemotherapy, with encouraging clinical results
[4, 5]. Radioembolization is increasingly being recognized
for treating liver tumors with a low rate of complications
among experienced teams [6–11]. The majority of adverse
events with radioembolization are caused by inadvertent
infusion of particles into nondetected extrahepatic vessels.
Nevertheless, a number of questions remain unanswered
regarding the observed complications with radioemboliza-
tion. Radiation-induced liver disease is unlikely to occur
[12] even though a more recent paper has described up to
20% mild to moderate radiation-induced liver disease in
cirrhotic patients [13]. Associated portal hypertension [14]
as well as gastritis or cholecystitis has also been described,
but it remains unclear whether these effects are related to
the radiation effects or the embolic effects of microspheres,
or to both. Moreover, it is not known whether the inter-
action between the particles and the vasculature has any
adverse effect on healthy liver. For better understanding of
these issues, we evaluated the ischemic effects of 90Y-free
(nonradioactive) resin microspheres using a well-known
pig model for embolization [15–18]. Embolization of the
kidney is a good model to evaluate the depth of penetration
of microspheres in the tissue and the resulting effects of
embolization as well as the particles themselves. We also
studied embolization of the liver, an organ with dual blood
supply, as it is the target organ for radioembolization.
However, our injection endpoint differed from clinical
practice, as we wanted to reach near-stasis in order to
evaluate side effects due to potential reflux of particles and
subsequent embolization of undesired organs. For this
reason, the histological study included the right liver lobe
and the gallbladder as well as the stomach. We also ana-
lyzed the lung in order to evaluate the possible presence of
particles that may have passed through physiologic arte-
riovenous shunts which are present in the healthy (nontu-
mor) liver parenchyma.
Materials and Methods
We performed a partial embolization of the liver and the
left kidney vessels in nine white pigs (Suis scrofa; weight,
*25 kg). The study design was approved by the ethics and
animal care committee of our institution and all procedures
were conducted in accordance with the European Com-
munity rules for animal care (Directive EC 86/609).
Aseptic measures were employed as in conventional
angiographic studies. Anesthesia was induced via an
intramuscular injection of azapirone (10 mg/kg body
weight) (Esteve, Barcelona) and ketamine (10 mg/kg body
weight; Merial, Barcelona) and inhalatory halothane
(0.8%–1%; Astra Zeneca, Madrid) combined with oxygen.
An electrocardiogram was used to monitor heart rate dur-
ing the procedure. The femoral artery was percutaneously
catheterized and an intra-arterial 4-Fr sheath (Cordis; L
Roden, Netherlands) placed into the artery. A 4-Fr cobra
catheter (Cordis) was employed to catheterize the left renal
and the left hepatic arteries, the latter because the right
usually divides proximally. The deployment of particles
was made through a 2.7 coaxial microcatheter (Progreat;
Terumo, Japan).
For each injection, a volume of resin microspheres
equivalent to a standard clinical dose of 3 GBq was pre-
pared. The resin microspheres were dispersed in 20 ml of
sterile water for injection into the kidney and 30 ml of
sterile water for injection in the liver. Using a three-way
stopcock, a 2-ml syringe was filled from the larger syringe
(20 or 30 ml). Particles were continuously shaken between
the two syringes and then slowly injected into the micro-
catheter with the 2-ml syringe.
Embolization was defined as the initiation of near-stasis
of blood flow. This end point was reached when contrast
medium was retained in the capillary network during three
successive heartbeats. On average, near-stasis was reached
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after injection of the contents of two syringes for the kid-
ney and three syringes for the liver (equivalent to 8 million
and 12 million resin microspheres, respectively). In order
to allow the possible retrograde passage of microspheres to
nontarget regions, when particles were applied to the left
hepatic artery, the gastroduodenal, right gastric, and other
extrahepatic arteries were not embolized as is usual prac-
tice in the clinic. This important difference from usual
clinical practice enabled us to observe the effects associ-
ated with reflux of particles into the lungs and stomach.
Pigs were sacrificed 48 h (n = 3), 4 weeks (n = 3), and
8 weeks (n = 3) following embolization. From each pig, 3-
mm-thick tissue slices were obtained. Seven transverse and
radial sections were obtained from the kidney, three or four
from each liver lobe perpendicular to the hilum (including
the gallbladder). At least six representative samples were
also obtained from the cardial and pyloric areas of the
stomach, and three to five sections from the lung. All tissue
samples were fixed with 10% buffered formaldehyde,
paraffin-embedded, and cut at 4 lm. They were stained
with the eosin/hematoxylin method for microscopic
evaluation.
From evaluation of samples of kidney tissue, records
were made of clustering of microspheres that could lead to
proximal occlusion of vessels as well as the penetration
depth of individual microspheres. In the liver, intra-arterial
deposition of microspheres (the presence of clusters lead-
ing to proximal tissue) was noted, as well as any tissue
pathology. Particularly, we observed possible damage to
the liver parenchyma, interaction between the spheres and
the portal tract, inflammation in the portal tracts, and
damage of the biliary tract and gallbladder endothelium. In
the lung and stomach, any potential damage due to the
presence of resin microspheres was recorded.
Vessels in which particles were found were classified
into three categories: small, medium, and large. Small
vessels were defined as those up to 30 lm (with particles
within them), corresponding in the kidney to afferent (\25-
lm) and arcuate (25- to 60-lm) arteries. Medium-sized
vessels were defined as those measuring from 30 to 90 lm,
corresponding to arcuate and interlobar arteries (60–
120 lm). Large vessels were defined as those larger than
150 lm, corresponding to interlobar and segmental arteries
(200–400 lm).
In the liver, small-caliber arteries were those from 10 to
30 lm, medium-sized arteries those from 30 to 100 lm,
and large arteries those [100 lm.
Results
The following section details the histological findings for
each time point. Results are summarized in Table 1.
Forty-Eight Hours Postembolization
Kidney
Macroscopically the kidney showed spotted to coalescent
white areas surrounded by hyperemia, corresponding to
small areas of acute infarction associated with emboliza-
tion. An intense inflammatory reaction composed of neu-
trophils and lymphocytes was associated with the infarcted
areas of the kidney parenchyma. When individual micro-
spheres were found within small vessels (glomerular
afferent vessels and arcuate arteries) (Fig. 1A), they did not
provoke any significant inflammatory reaction around the
vessels.
Liver
No macroscopic changes were observed. In the liver, par-
ticles were homogeneously distributed inside small-sized
vessels, both in large and small portal spaces and in sub-
capsular arteries throughout the entire left liver lobe.
Aggregates inside large and medium-sized vessels were
found and were associated with fibrinoid necrosis of the
vessel wall. Single microspheres were extensively diffused
in small portal spaces as well as in capsular arteries. There
were no signs of ischemia or tissue damage in the paren-
chyma (Fig. 1B) or biliary tract.
Lung and Stomach
Following administration of spheres into the left hepatic
artery, up to 30 spheres were found in the three lung tissue
samples due to arteriovenous shunting. They were distrib-
uted throughout the lung vasculature and were individually
found in the alveolar capillaries, causing mild dilatation
and a slight inflammatory reaction (Fig. 1C).
Resin microspheres were found in the vessels through-
out all layers of the stomach (from the mucosa to serosa).
Single spheres found in the vasculature of the mucosal
layer produced mild perivascular inflammation. When
aggregates were found in vessels of the serosa, the mus-
cular layer, and, occasionally, the submucosa, they tended
to lead to lumen occlusion. Clusters were associated with
arterial wall changes and mild periarteritis, except in one
case of marked gastritis and ulceration at the site of arterial
occlusion (Fig. 1D).
Four Weeks After Embolization
Kidney
Macroscopic observation of the kidney showed an irregular
surface with small white-gray-colored retracted areas of
J. I. Bilbao et al.: Biocompatibility, Inflammatory Response, and Recannalization Characteristics 729
123
T
a
b
le
1
H
is
to
lo
g
ic
al
fi
n
d
in
g
s
in
th
e
k
id
n
ey
,
li
v
er
,
lu
n
g
an
d
st
o
m
ac
h
K
id
n
ey
L
iv
er
4
8
h
4
w
k
8
w
k
4
8
h
4
w
k
8
w
k
S
iz
e
(l
m
±
S
D
)
2
1
.5
0
6
±
3
.2
9
8
(n
=
9
7
)
2
0
.6
1
9
±
3
.0
1
1
(n
=
4
8
)
L
o
ca
ti
o
n
(v
es
se
l
si
ze
)
L
ar
g
e
?
?
?
?
M
ed
iu
m
?
?
?
?
S
m
al
l
?
?
?
?
?
?
?
D
is
tr
ib
u
ti
o
n
In
d
iv
id
u
al
ly
?
?
?
?
?
?
?
A
g
g
re
g
at
es
?
?
,
5
to
3
0
p
ar
ti
cl
es
p
er
v
es
se
l
?
?
C
h
an
g
es
in
ar
te
ri
al
w
al
l
W
al
l
d
is
te
n
si
o
n
,
ac
u
te
p
er
ia
rt
er
it
is
F
ib
ri
n
o
id
n
ec
ro
si
s
w
h
en
g
ro
u
p
ed
?
?
,
p
er
iv
as
cu
la
r
fi
b
ro
si
s,
ep
it
h
el
iz
at
io
n
o
f
g
ro
u
p
ed
p
ar
ti
cl
es
W
al
l
d
is
te
n
si
o
n
F
ib
ri
n
o
id
n
ec
ro
si
s
w
h
en
g
ro
u
p
ed
?
?
,
p
er
iv
as
cu
la
r
fi
b
ro
si
s,
ep
it
h
el
iz
at
io
n
o
f
g
ro
u
p
ed
p
ar
ti
cl
es
T
is
su
e
d
am
ag
e
A
cu
te
in
fa
rc
ti
o
n
R
et
ra
ct
io
n
R
et
ra
ct
io
n
,
sc
ar
fo
rm
at
io
n
–
–
–
In
fl
am
m
at
o
ry
in
fi
lt
ra
te
L
y
m
p
h
o
cy
te
s,
n
eu
tr
o
p
h
il
s
in
tr
a-
an
d
p
er
iv
as
cu
la
r
L
y
m
p
h
o
cy
te
s,
m
ac
ro
p
h
ag
es
M
G
C
s
M
ac
ro
p
h
ag
es
,
M
G
C
s
L
y
m
p
h
o
cy
te
s,
n
eu
tr
o
p
h
il
s
L
y
m
p
h
o
cy
te
s,
m
ac
ro
p
h
ag
es
M
ac
ro
p
h
ag
es
,
M
G
C
s
E
m
b
o
li
ze
d
te
rr
it
o
ri
es
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
R
el
at
ed
to
p
ar
ti
cl
es
–
/?
si
n
g
le
,
?
?
?
g
ro
u
p
ed
–
/?
si
n
g
le
,
?
?
?
g
ro
u
p
ed
–
/?
si
n
g
le
,
?
?
?
g
ro
u
p
ed
–
/?
si
n
g
le
,
?
?
g
ro
u
p
ed
V
es
se
l
re
ca
n
n
al
iz
at
io
n
/
n
eo
fo
rm
at
io
n
–
R
ec
an
n
al
iz
at
io
n
R
ec
an
n
al
iz
at
io
n
/c
o
ll
at
er
al
n
eo
v
es
se
ls
–
R
ec
an
n
al
iz
at
io
n
R
ec
an
n
al
iz
at
io
n
/c
o
ll
at
er
al
n
eo
v
es
se
ls
L
u
n
g
S
to
m
ac
h
4
8
h
4
w
k
8
w
k
4
8
h
4
w
k
8
w
k
S
iz
e
(l
m
±
S
D
)
2
0
.1
6
3
±
3
.1
3
8
(n
=
1
4
)
2
1
.6
3
9
±
3
.0
5
2
(n
=
5
4
)
L
o
ca
ti
o
n
(v
es
se
l
si
ze
)
L
ar
g
e
–
?
?
M
ed
iu
m
–
?
?
S
m
al
l
?
?
?
?
D
is
tr
ib
u
ti
o
n
In
d
iv
id
u
al
ly
?
?
?
?
?
A
g
g
re
g
at
es
–
?
?
?
C
h
an
g
es
in
ar
te
ri
al
w
al
l
W
al
l
d
is
te
n
si
o
n
–
–
W
al
l
d
is
te
n
si
o
n
,
p
er
ia
rt
er
it
is
F
ib
ri
n
o
id
n
ec
ro
si
s
w
h
en
g
ro
u
p
ed
E
p
it
h
el
iz
at
io
n
o
f
p
ar
ti
cl
es
w
h
en
g
ro
u
p
ed
T
is
su
e
d
am
ag
e
–
–
–
–
–
–
730 J. I. Bilbao et al.: Biocompatibility, Inflammatory Response, and Recannalization Characteristics
123
infarction. Microscopically the kidney showed a large
number of microspheres (size, 21.4 ± 3.6 lm) distributed
homogeneously within renal parenchyma, mainly in the
renal cortex. Two patterns of microsphere distribution were
observed: individual spheres inside small vessels and
clusters of particles (5 to 30 in number) within medium-
sized to large arteries. The most frequent pattern of dis-
tribution was individual spheres inside the arcuate arteries,
afferent glomerular arteries, and glomeruli. In these cases,
perivascular inflammatory reaction was very mild or
absent, with macrophage proliferation and a few multinu-
cleated giant cells (MGCs). The microspheres were inte-
grated into the vascular wall and the arterial lumen was
recannalized (Fig. 2A).
Liver
Macroscopically, no alterations were observed. Micro-
scopical study showed that microspheres were homoge-
neously distributed inside small vessels, in both portal
tracts and subcapsular arteries of the left liver lobe.
Inflammatory reaction was mild or absent and signs of
injuries were not found in the surrounding portal space
structures or the liver parenchyma (Fig. 2B).
Lung and Stomach
A small number of spheres were localized in the alveolar
walls of the lung.
In the stomach, individual and clusters of microspheres
were found in small vessels of the lamina propria next to
the epithelium (Fig. 2C), as well as within vessels in the
submucosa and muscular layer. Microspheres were found
within arteries in the mucosa layer and recannalization of
the vessels was observed. The presence of large aggregates
of microspheres was associated with a perivascular,
inflammatory reaction (mononuclear cells, macrophages,
and MGCs).
Two Months After Embolization
Kidney
Macroscopic observation of the kidney revealed an irregu-
lar surface with scar tissue retraction and areas of cortical
thinning. Microscopic observation showed that micro-
spheres were distributed throughout the kidney paren-
chyma, but with a higher accumulation in the afferent
glomerular arteries and, occasionally, the glomeruli. Com-
pared with observations at 48 h, there were fewer thrombi
and microspheres were either embedded in or excludedT
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from the arterial walls (Fig. 3A). In the majority of cases,
tissues were revascularized following recannalization of the
occluded vessel or neovascularization. Associated perivas-
cular inflammatory reaction was mild for both single
spheres and clusters consisting of mainly lymphocytic
infiltrate and MGCs showing sphere phagocytosis.
Liver
Microspheres were found in vessels of different sizes of the
liver reaching the subcapsular arteries. Consistent with
observations at 48 h and 4 weeks, two patterns of distri-
bution were found: single spheres reaching the small portal
Fig. 1 A Findings at 48 h.
Kidney. Two particles within an
afferent glomerular artery. No
inflammatory reaction
associated with this finding was
seen. (H&E; original
magnification, 9400). B
Findings at 48 h. Liver. Single
sphere in a portal space. No
hepatocyte damage or ischemic
phenomena were seen. (H&E;
original magnification, 9200).
C Findings at 48 h. Lung.
Particles within an interalveolar
septum with very few
surrounding inflammatory cells.
(H&E; original magnification,
9400). D Findings at 48 h.
Stomach. Small particle
thrombus (arrow) leading to
gastritis and ulceration of
gastric epithelium. (H&E;
original magnification, 9100)
Fig. 2 A Findings at 1 month.
Kidney. Particles embedded by
the arterial wall. Blood flow was
restored by recannalization of
vessels (arrow). (H&E; original
magnification, 9400). B
Findings at 1 month. Liver.
Particles within a portal space
without any associated
abnormal histologic finding.
(H&E; original magnification,
9200). C Findings at 1 month.
Stomach. Some spheres are seen
inside the lamina propria vessels
next to the epithelium. (H&E;
original magnification, 9100)
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spaces and, less frequently, aggregates of microspheres in
the large portal tracts. Microspheres were embedded in the
arterial wall, leading to vessel recannalization (Fig. 3B).
Perivascular inflammatory reaction was mild and neither
liver cell damage, bile duct injury (Fig. 3C), nor portal
space fibrosis (some portal tracts showed slight fibrosis)
was observed (Fig. 3D). One case of intense cholecystitis
occurred and was associated with epithelial ulceration,
thrombosis, ischemia, and inflammation. In this last case, a
large number of individual spheres were seen within the
gallbladder wall, some reaching the gallbladder lumen
(Fig. 3E).
Lung and Stomach
Very few microspheres were located within the lung
interalveolar septum arterioles. No inflammatory reaction
was observed (Fig. 3F).
In the stomach, individual spheres were located inside the
serosa, the muscular layer, the submucosa, and the lamina
propia, but without an associated inflammatory reaction.
Aggregates were also found within the muscular and sub-
mucosa layers of the arteries. Blood flow was re-established
and particle aggregates were surrounded by a mild foreign
body reaction, with mononuclear and multinucleated cells.
In summary, the following observations were made. The
size of the microspheres ranged between 18 and 25 lm.
Microspheres were found in the small arteries and arterioles.
Clusters of microspheres tended to be associated focal
ischemia of the vascular walls with a mild to moderate
perivascular inflammatory reaction. Aggregates were found
in all specimens, with the exception of the lung. For the most
part, individual microspheres did not provoke either vessel
wall damage or a perivascular inflammatory reaction.
After 1 to 2 months, particles tended to be incorporated
within the vessel wall, causing a mild extravascular foreign
Fig. 3 A Findings at 2 months.
Kidney. Complete
recannalization of an interlobar
artery and exclusion of particles
from it (arrow). A slight
associated inflammatory
reaction was observed. (H&E;
original magnification, 9200).
B Findings at 2 months. Liver.
Recannalization of an artery
formerly occluded by a group of
particles that have been
excluded from the artery
(arrow). A very mild
inflammatory reaction
associated with the particles.
(H&E; original magnification,
9400). C Findings at 2 months.
Liver. Particles within a large
portal space. No bile duct
damage was noted. (H&E;
original magnification, 9200).
D Findings at 2 months. Liver.
Two particles in a small portal
space. Absence of fibrosis and
inflammatory reaction. (H&E;
original magnification, 9400).
E Findings at 2 months.
Gallbladder. Inflammation,
erosion, and epithelial
ulceration of the gallbladder
wall due to ischaemia. A
particle within the gallbladder
lumen is visible. (H&E; original
magnification, 9100). F
Findings at 2 months. Lung.
Particles within an interalveolar
septum without surrounding
inflammatory cells. (H&E;
original magnification, 9400)
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body reaction. With the exclusion of microspheres from the
vessel lumen, blood flow was re-established due to either
vessel recannalization or neovascularization (new vessel
formation).
We found one case of cholecystitis as well as one case
of marked gastritis and ulceration at the site of arterial
occlusion due to the presence of clusters of microspheres.
Ischemic sequelae were mild to moderate in the kidney
and almost absent in the liver.
Discussion
Radioembolization is an effective method for inducing liver
tumor regression. The results of several clinical studies have
supported its use and confirmed its efficacy in the treatment
of primary [10, 11] and metastatic [7–9] liver neoplasm. The
incidence of complications after radioembolization is low, if
patients are selected appropriately and target delivery is
performed meticulously [2]. Gastrointestinal complications
have been reported to occur in 3% to 29% of patients treated
with radioembolization [19], however, little is known about
the mechanism of injury underlying these complications
[19–21]. Similar gastrointestinal complications have also
been observed after chemoembolization [22] and intra-
arterial infusion of chemotherapy [23]. Gastric and duodenal
ulcerations are caused by untargeted delivery of particles in
the gastroduodenal territories via extrahepatic visceral
arterial branches [2]. In radioembolization, as in other
intraarterial liver procedures, this risk can be minimized by
occluding extra hepatic visceral arteries prior to adminis-
tration of microspheres [24, 25].
Although radioembolization is, technically, an emboli-
zation procedure since particles are administered intra-
arterially, and vascular occlusion is expected, the aim of
the procedure is not to occlude vessels but to deliver a
lethal dose of radioactivity in the tumor via its arterial/
arteriolar network. Maintaining adequate oxygenation of
the tumor tissue increases the lethal effect of the radiation,
and an important ischemia, due to a large tissue emboli-
zation, could then limit the efficacy of the treatment [1].
Additionally, it is important that particles reach the perit-
umoral and intratumoral vessels, in order to deliver 90Y as
close as possible to the tumor cells and to limit proximal
occlusion and extratumoral irradiation. For these reasons,
particles must be small enough (\30 lm) to reach the
tumor microvasculature. Clustering of microspheres
(scarcely observed in our study) could be due to an
unavoidable intraprocedural arterial spasm but also to an
inherent tendency of the microspheres to aggregate.
As expected in the kidney (an organ with terminal arterial
vascularization), the acute vascular occlusion caused
ischemia and infarct of the parenchyma. Clusters, rather than
individual microspheres, were found to provoke a mild to
moderate perivascular inflammatory reaction. Individual
particles found as distally as in the intraglomerular arteries
were not found to provoke any kind of local reaction.
In the liver, particles were initially found within the
vascular lumen, without any associated damage to the bile
ducts or parenchyma. At 2 months, most of the micro-
spheres had been excluded from the vessel lumen, being
either incorporated into the vessel wall or completely
excluded from the arteries. When particles were excluded
into the perivascular tissue, a mild perivascular foreign
body reaction was observed, associated with a recannal-
ization of the vessel.
Recent experimental studies [16–18], performed with
several embolic particles (size, between 40 and 900 lm),
have demonstrated that the presence of a foreign body
reaction is generally low, though different between agents.
The presence of giant cells was more frequently associated
with small sizes, especially after embolization with small
Tris-acryl gelatin (Embosphere) particles. The present
study demonstrates that, in the liver, the foreign body
reaction was very low or even absent with the studied
microspheres (18–25 lm).
A large number of individual spheres were found in the
different layers (muscular, submucosa, and mucosa) of the
stomach, with minimal associated inflammatory reaction.
When aggregations of particles were found, blood flow was
re-established by neovascularization. In one case (48 h
after the embolization), gastritis associated with arterial
occlusion (a cluster of particles) was seen.
All tissue samples showed microspheres within the gall-
bladder layers. A sample (after 2 months) showed evident
histological signs of active ischemic cholecystitis. It is well
known that cholecystitis may occur after arterial emboliza-
tion using particles of different sizes and characteristics. In
the radioembolization procedure, microspheres may migrate
through the cystic artery to the gallbladder. Although cases
of characteristic thick-walled appearance of the gallbladder
have been observed and reported, the risk of cholecystitis
requiring cholecystectomy is low [26]. In order to avoid this
complication, injection should be performed placing the
catheter tip distally to the cystic artery. However, numerous
anatomical variations of the origin of the cystic artery/
arteries can preclude such positioning of the catheter. The
best way to avoid migration of particles into the gallbladder
and the resulting complications is still open to debate. This
experimental study demonstrates that cholecystitis, caused
exclusively by ischemia, may appear after the administra-
tion of microspheres.
A few particles were found in the lung in all samples. At
2 days the presence of microspheres was associated with
mild dilatation and slight inflammatory reaction of the
alveolar capillaries. This inflammatory reaction was not
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observed in subsequent observations at 4 and 8 weeks. In
healthy liver parenchyma, particles of small size may pass
through direct connections from the hepatic arterioles to
the sinusoids, described by Breen et al. as transsinusoidal
connections [27]. This could explain why some spheres
were found in the lung.
The limitations of this study are, first, that our maximum
follow-up was 8 weeks. At this time, spheres seem to be
‘‘inert,’’ with no effect on the liver parenchyma cells.
However, since particles are excluded from the vessel into
the perivascular space and cause an extravascular foreign
body reaction, they may, over time, induce fibrosis in the
portal spaces. Additional, longer-term evaluation is needed.
The second limitation is the relatively small number of
animals (nine), divided into three groups. However, in our
view, the information provided about biocompatibility and
performance of the microspheres is useful and representa-
tive since we obtained samples from the kidney (terminal
vessel organ), the liver (with dual blood supply), and all the
other viscera that could be involved when a ‘‘nontargeted’’
radoembolization occurs.
Third, it could be argued that our study is limited by the
large quantity of particles injected, the endpoint of injection,
and the method of injection. However, our objective was to
evaluate the embolic effect of these particles. For this rea-
son, we chose near -stasis as the embolization endpoint in
order to mimic the worst clinical situation. Our objective
was to demonstrate that, even in the worst situation, the
damage caused by these particles was limited. However,
these results should not be understood as evidence that stasis
should be the objective of radioembolization.
In conclusion, when microspheres (18 to 25 lm) are
found individually they occlude distal, small vessels with
mild or no associated perivascular inflammatory reaction.
Particles are excluded from the vascular lumen by a
phagocytosis process, with subsequent recannalization of
the embolized arteries. Vascular occlusion has an ischemic
effect on organs with terminal vascularization such as the
kidney. No ischemic complications were observed in the
liver parenchyma in our study. Although infrequent, par-
ticles have a tendency to aggregate (10–30 spheres) and
occlude proximal vessels; this may lead to ischemic com-
plications (i.e., gastric ulceration). In radioembolization
with resin microspheres the complications rate and their
severity are mainly related to the irradiating effect rather
than the embolizing effect.
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